| Apellido | CHUNG |
| Nombre | HYUN-CHEOL |
| ID | 6560275 |
"Su solicitud se enviará en seg. Por favor espere."
SUGERENCIAS
Chung, Hery Autor ID: 1311837 ver autor
Articulos ( 10 en total, se muestran 3 )
● 2D-QSAR and 3D-QSAR/CoMSIA Studies on a Series of (R)-2-((2-(1H-Indol-2-yl)ethyl)amino)-1-Phenylethan-1-ol with Human beta(3)-Adrenergic Activity, 2017
● Cannabidiol binding and negative allosteric modulation at the cannabinoid type 1 receptor in the presence of delta-9-tetrahydrocannabinol: An <i>In Silico</i> study, 2019
● Combined CoMFA and CoMSIA 3D-QSAR study of benzimidazole and benzothiophene derivatives with selective affinity for the CB2 cannabinoid receptor, 2017
Afiliaciones ( 1 en total )
● Pontificia Universidad Católica de Chile
Chung, Hery Autor ID: 5311968 ver autor
Articulos ( 1 en total )
● New Pyridone-Based Derivatives as Cannabinoid Receptor Type 2 Agonists, 2021
Afiliaciones ( 1 en total )
● Pontificia Universidad Católica de Chile
ÁREA DE TRABAJO
FIRMA SELECCIONADA COMO BASE
Chung, Hyun-Cheol Autor ID: 6560275 ver autor
Articulos ( 31 en total, se muestran 3 )
● Albumin as a simple criterion to reduce early mortality (EM) in gastric cancer (GC) trials, 2020
● Association between gene expression signatures and clinical outcomes of pembrolizumab versus paclitaxel in advanced gastric cancer: exploratory analysis from the randomized, controlled, phase III KEYNOTE-061 trial, 2023
● Association between gene expression signatures and outcomes of pembrolizumab (pembro) and paclitaxel (pac) in advanced gastric cancer (GC): Exploratory analysis from KEYNOTE-061, 2022
Afiliaciones ( 5 en total, se muestran 3 )
● Yonsei Canc Ctr
● Yonsei Cancer Center
● Yonsei Cancer Hospital
FIRMAS SELECCIONADAS PARA AGRUPAR